CD38 knockout natural killer cells expressing an affinity optimized CD38 chimeric antigen receptor successfully target acute myeloid leukemia with reduced effector cell fratricide | Haematologica
Detect CD38 expression during anti-CD38 therapy – Caltag Medsystems
-Flow-Cytometry-NB500-510-img0011.jpg "CD38 Antibody (HIT2) - BSA Free (NB500-510): Novus Biologicals")
CD38 Antibody (HIT2) - BSA Free (NB500-510): Novus Biologicals
CD38 expression and function in NK cells. (A) Role of CD38 in the... | Download Scientific Diagram
CD20 and CD38 expression on normal and CLL B-cells. Cells were... | Download Scientific Diagram
CD38 expression and complement inhibitors affect response and resistance to daratumumab therapy in myeloma - ScienceDirect
Cells | Free Full-Text | Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma | HTML
Hierarchy of CD38 expression across immune subtypes in bone-marrow... | Download Scientific Diagram
Frontiers | CD38 Is Robustly Induced in Human Macrophages and Monocytes in Inflammatory Conditions
Pre-treatment CD38-positive regulatory T cells affect the durable response to daratumumab in relapsed/refractory multiple myeloma patients | Haematologica
![PDF] CD38 and Regulation of the Immune Response Cells in Cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c705fe469b5966b746cb77a8063ac6adff11c2ee/3-Figure1-1.png "PDF] CD38 and Regulation of the Immune Response Cells in Cancer | Semantic Scholar")
PDF] CD38 and Regulation of the Immune Response Cells in Cancer | Semantic Scholar
CD38, A Target for Immunotherapeutic Approaches in Cancer
CD38 | SpringerLink
CD38 affects the biological behavior and energy metabolism of nasopharyngeal carcinoma cells
Frontiers | CD38: A Target for Immunotherapeutic Approaches in Multiple Myeloma
Cells | Free Full-Text | The Many Facets of CD38 in Lymphoma: From Tumor–Microenvironment Cell Interactions to Acquired Resistance to Immunotherapy | HTML
Flow cytometric evaluation of CD38 expression levels in the newly diagnosed T-cell acute lymphoblastic leukemia and the effect of chemotherapy on its expression in measurable residual disease, refractory disease and relapsed disease:
CD38 - Wikipedia
Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab | Leukemia
CD38 at the junction between prognostic marker and therapeutic target: Trends in Molecular Medicine
CD38 and Regulation of the Immune Response Cells in Cancer
Expanding anti-CD38 immunotherapy for lymphoid malignancies | Journal of Experimental & Clinical Cancer Research | Full Text
Targeting CD38-dependent NAD+ metabolism to mitigate multiple organ fibrosis - ScienceDirect
Cells | Free Full-Text | CD38 Expression by Myeloma Cells and Its Role in the Context of Bone Marrow Microenvironment: Modulation by Therapeutic Agents
